Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
-7.87%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
-$100M
Cap. Flow %
-0.83%
Top 10 Hldgs %
34.84%
Holding
1,453
New
30
Increased
610
Reduced
359
Closed
38

Sector Composition

1 Real Estate 59.2%
2 Technology 9.45%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RVMD icon
1126
Revolution Medicines
RVMD
$7.65B
$5K ﹤0.01%
277
SWTX
1127
DELISTED
SpringWorks Therapeutics
SWTX
$5K ﹤0.01%
184
TVTX icon
1128
Travere Therapeutics
TVTX
$1.93B
$5K ﹤0.01%
208
ZNTL icon
1129
Zentalis Pharmaceuticals
ZNTL
$115M
$5K ﹤0.01%
212
KDNY
1130
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$5K ﹤0.01%
230
ACRS icon
1131
Aclaris Therapeutics
ACRS
$231M
$4K ﹤0.01%
248
ADPT icon
1132
Adaptive Biotechnologies
ADPT
$1.92B
$4K ﹤0.01%
530
AKRO icon
1133
Akero Therapeutics
AKRO
$3.57B
$4K ﹤0.01%
119
AUPH icon
1134
Aurinia Pharmaceuticals
AUPH
$1.63B
$4K ﹤0.01%
528
CRNX icon
1135
Crinetics Pharmaceuticals
CRNX
$3.44B
$4K ﹤0.01%
199
DAWN icon
1136
Day One Biopharmaceuticals
DAWN
$759M
$4K ﹤0.01%
181
ENTA icon
1137
Enanta Pharmaceuticals
ENTA
$193M
$4K ﹤0.01%
69
FGEN icon
1138
FibroGen
FGEN
$46.4M
$4K ﹤0.01%
13
GMAB icon
1139
Genmab
GMAB
$17.1B
$4K ﹤0.01%
137
MDGL icon
1140
Madrigal Pharmaceuticals
MDGL
$10B
$4K ﹤0.01%
57
PACB icon
1141
Pacific Biosciences
PACB
$393M
$4K ﹤0.01%
682
PCVX icon
1142
Vaxcyte
PCVX
$4.25B
$4K ﹤0.01%
179
RGNX icon
1143
Regenxbio
RGNX
$500M
$4K ﹤0.01%
146
RYTM icon
1144
Rhythm Pharmaceuticals
RYTM
$6.74B
$4K ﹤0.01%
172
SNDX icon
1145
Syndax Pharmaceuticals
SNDX
$1.37B
$4K ﹤0.01%
167
VCYT icon
1146
Veracyte
VCYT
$2.52B
$4K ﹤0.01%
266
DCPH
1147
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
199
BLU
1148
DELISTED
BELLUS Health Inc.
BLU
$4K ﹤0.01%
398
KROS icon
1149
Keros Therapeutics
KROS
$638M
$3K ﹤0.01%
80
PLRX icon
1150
Pliant Therapeutics
PLRX
$107M
$3K ﹤0.01%
123